Indo Us Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2025_Book Closure Notice for AGM
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited (NSE: INDOUS, BSE: 541304) has informed the exchanges about its 21st Annual General Meeting scheduled for Tuesday, September 30, 2025, at 2:30 PM, to be held via Video Conferencing. The Register of Members and Share Transfer Books will remain closed from Tuesday, September 23, 2025, to Tuesday, September 30, 2025 (both days inclusive). Shareholders as on the cut-off date of September 23, 2025, can vote electronically between September 27 (9:00 AM) and September 29 (5:00 PM). Key business to be transacted includes: (1) adoption of FY25 audited financials, (2) reappointment of Mrs. Malti J. Ajudia as Director (retiring by rotation), (3) approval to raise borrowing limits to Rs. 250 crore and create charges up to Rs. 100 crore, (4) approval for related party transactions up to Rs. 10 crore per type, (5) reappointment of Mr. Jagdish Ajudiya as Managing Director for 5 years (Nov 2025 to Nov 2030) with a basic salary of Rs. 1,08,000 per month, and (6) appointment of internal and secretarial auditors.
Shareholders should note the book closure period (Sept 23–30, 2025) — no share transfers will be processed during this window. The proposed 5-year reappointment of the promoter Managing Director and higher borrowing limits (Rs. 250 crore) are routine but noteworthy, while the related party transaction approval up to Rs. 10 crore is a standard governance requirement.